Prednisone delayed release (PREDNISONE)
Prednisone delayed release (PREDNISONE) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Prednisone delayed release; Generic name: PREDNISONE; Drug class: Corticosteroid [EPC].
| Brand name | Prednisone delayed release |
|---|---|
| Generic name | PREDNISONE |
| Drug class | Corticosteroid [EPC] |
| Manufacturer | Dr. Reddys Laboratories Inc. |
| Used for | 1 INDICATIONS AND USAGE Prednisone delayed-release tablets are indicated in the treatment of the following diseases or conditions: Prednisone delayed-release tablets are a corticosteroid indicated as an anti-inflammatory or immunosuppressive agent for certain allergic, dermatologic, gastrointestinal, hematologic, ophthalmologic, nervous system, renal, respiratory, rheumatologic, specific infectious diseases or conditions and organ transplantation ( 1 ) for the treatment of certain endocrine conditions ( 1 ) for palliation of certain neoplastic conditions ( 1 ) 1.1 Allergic Conditions Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatm |
| Dosage | 2 DOSAGE AND ADMINISTRATION Individualize dosing based on disease severity and patient response. The timing of administration should take into account the delayed-release pharmacokinetics and the disease or condition being treated ( 2 , 12.1 ): Initial dose: Prednisone delayed-release tablets 5 mg administered once per day. Patients currently on immediate-release prednisone, prednisolone, or methylprednisolone should be switched to prednisone delayed-release tablets at an equivalent dose based o |
| Active ingredient(s) | PREDNISONE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=01bdc479-1f1f-af94-837c-12e7e861321a |